This inventor holds 2 USPTO granted patents. Top assignee: Takara Shuzo Co., Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Hideharu Saito
Introduction
Hideharu Saito is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of immunology and antibiotic development. With a total of 2 patents, Saito's work has the potential to impact the treatment of various immunological diseases.
Latest Patents
Saito's latest patents include groundbreaking research on the inhibition of IgA production. This patent details a method for selectively inhibiting IgA production by orally administering 15-deoxyspergualin or its pharmacologically acceptable salts. This innovation aims to prevent and treat IgA-associated immunological diseases, such as IgA nephropathy. Another significant patent is for Antibiotic TKR2648, which includes a process for producing this antibiotic with a specific chemical formula or its pharmacologically acceptable salt.
Career Highlights
Saito is currently associated with Takara Shuzo Co., Inc., where he continues to innovate and develop new solutions in his field. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Saito has collaborated with notable colleagues, including Ikunoshin Kato and Kazutoh Takesako. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Hideharu Saito's contributions to immunology and antibiotic development highlight his role as a significant inventor in the medical field. His innovative patents reflect a dedication to addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile